Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Authors:
- Leonardo LorenteLLLeonardo Lorente
- María M MartínMMMaría M Martín
- Nerea VaroNVNerea Varo
- Juan María Borreguero-LeónJBJuan María Borreguero-León
- Jordi Solé-ViolánJSJordi Solé-Violán
- José BlanquerJBJosé Blanquer
- Lorenzo LabartaLLLorenzo Labarta
- César DíazCDCésar Díaz
- Alejandro JiménezAJAlejandro Jiménez
- Eduardo PastorEPEduardo Pastor
- Felipe BelmonteFBFelipe Belmonte
- Josune OrbeJOJosune Orbe
Open Access
- 15 March 2011
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 15 (2) , R97
Abstract
Introduction: CD40 Ligand (CD40L) and its soluble counterpart (sCD40L) are proteins that exhibit prothrombotic and proinflammatory properties on binding to their cell surface receptor CD40. The results of small clinical studies suggest that sCD40L levels could play a role in sepsis; however, there are no data on the association between sCD40L levels and mortality of septic patients. Thus, the aim of this study was to determine whether circulating sCD40L levels could be a marker of adverse outcome in a large cohort of patients with severe sepsis. Methods: This was a multicenter, observational and prospective study carried out in six Spanish intensive care units. Serum levels of sCD40L, tumour necrosis factor-alpha and interleukin-10, and plasma levels of tissue factor were measured in 186 patients with severe sepsis at the time of diagnosis. Serum sCD40L was also measured in 50 age- and sex-matched controls. Survival at 30 days was used as the endpoint. Results: Circulating sCD40L levels were significantly higher in septic patients than in controls (P = 0.01), and in non-survivors (n = 62) compared to survivors (n = 124) (P = 0.04). However, the levels of CD40L were not different regarding sepsis severity. Logistic regression analysis showed that sCD40L levels >3.5 ng/mL were associated with higher mortality at 30 days (odds ratio = 2.89; 95% confidence interval = 1.37 to 6.07; P = 0.005). The area under the curve of sCD40L levels >3.5 ng/mL as predictor of mortality at 30 days was 0.58 (95% CI = 0.51 to 0.65; P = 0.03). Conclusions: In conclusion, circulating sCD40L levels are increased in septic patients and are independently associated with mortality in these patients; thus, its modulation could represent an attractive therapeutic target.Keywords
This publication has 50 references indexed in Scilit:
- Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcomeIntensive Care Medicine, 2010
- Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary reportBMC Pulmonary Medicine, 2009
- Increased Synthesis of Anti-Tuberculous Glycolipid Immunoglobulin G (IgG) and IgA with Cavity Formation in Patients with Pulmonary TuberculosisClinical and Vaccine Immunology, 2008
- CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injuryBlood, 2006
- Internalization of CD40 regulates its signal transduction in vascular endothelial cellsBiochemical and Biophysical Research Communications, 2006
- Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shockInternational Journal of Cardiology, 2004
- Upregulation of CD40-CD40 Ligand (CD154) in Patients With Acute Cerebral IschemiaStroke, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- APACHE IICritical Care Medicine, 1985